ArticleFrontiers in immunology2022

Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin.

Junlin Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.